Krishna Institute of Medical Sciences Limited (KIMS) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Krishna Institute of Medical Sciences Limited stock ₹126, price ₹763, that is 83.4% below the price, quality 37 out of 100. Rating: strongly overvalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Krishna Institute of Medical Sciences Limited
KIMS · NSEFar too expensive (fair value 83% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.
How to read this chart
60‑month range ₹215.90 – ₹850.65 · fair‑value band ₹94.83 – ₹158.06 · the ₹763.35 price screens above the ₹126.45 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.
Every Wednesday you see whether Krishna Institute of Medical Sciences is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India.
Show moreShow less
The company offers arthroscopy and shoulder, cardiology, cardiothoracic and cardiovascular, organ transplant, medical and surgical gastroenterology, hepatology, orthopaedic, neurology, neurosurgery, nephrology, urology, oncology, pediatric, neonatology, obstetrics and gynaecology, fertility, dental science, emergency and critical care, vascular, rehabilitation and physiotherapy services.
It also provides pulmonology, diagnostic and imaging, ophthalmology, ENT, rheumatology and clinical immunology, internal medicine, interventional radiology, diabetology, endocrinology, general surgery, infectious disease, dermatology, thoracic surgery, psychiatry, plastic and reconstructive surgery, transfusion medicine, clinical psychology, anesthesiology, and tele medicine services.
In addition, the company operates clinical immunology allergy, bone marrow transplantation, hair transplant, andrology, fertility, alzheimer, arthroscopy, bone and joint, breast, dialysis, female urology, IUI, IVF, joint replacement, kidney health and transplant, ICU, spine, stroke, TAVR/TAVI, hepatobiliary surgery, and trauma centers, as well as pain and wellness clinics.
Further, it provides bariatric, thoracic, oral maxillofacial, and endovascular surgery services. Krishna Institute of Medical Sciences Limited was incorporated in 1973 and is based in Secunderabad, India.
Stock analysis
Krishna Institute of Medical Sciences Limited (KIMS) currently trades at ₹763.35, while our model-based Fair Value estimate is ₹126.45, 83% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹174.65 per share, and 0 of the 14 models we run sit above the ₹763.35 price.
Bear case: the Asset-Based group reads lowest at ₹29.54, and 14 of the 14 models stay below the price. Data coverage for this calculation is low.
Scenario range: ₹94.83 (bear) to ₹158.06 (bull), the price of ₹763.35 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 37/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Krishna Institute of Medical Sciences Limited reported revenue of ₹39.0B in FY2026 versus ₹16.5B in FY2022, a compound +24.0%/yr. Reported net income was ₹2.4B in FY2026, compounding −7.7%/yr from FY2022.
Key figures
Market cap ₹306B (≈ $3.2B) Mid · P/E ratio 146.2 · P/S ratio 7.25 · EPS (TTM) ₹5.22 · Net margin 4.9% · Return on equity 9.7% · Return on assets (EBIT) 14.1% (5-year average) · Operating margin 10.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 40 out of 100 (low confidence).
What moves the price
The last reported earnings sit well below what analysts expect (earnings in transition, for example after write-downs or an earnings dip); whether the stock is cheap or expensive hinges on the expected recovery actually arriving. Read the fair value with that caveat.
The share trades about 10% below its 52-week high and 31% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −2% fair-value upside, at −83%, KIMS screens richer than that median.
Fair Value models
All 14 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
KIMS screens overvalued: fair value 83% below the price. Compare with HCA Healthcare, Inc →
Compare Krishna Institute of Medical Sciences Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 249 stocks
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Quality Score by industry
- Return on equity by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Fresenius Medical Care AG FMS | $22.03 | $45.73 | +108% | vs KIMS |
| DaVita Inc DVA | $174.56 | $218.90 | +25% | vs KIMS |
| Aier Eye Hospital Group 300015 | ¥8.99 | ¥10.88 | +21% | vs KIMS |
| HCA Healthcare, Inc HCA | $499.05 | $547.34 | +10% | vs KIMS |
| Tenet Healthcare Corporation THC | $286.03 | $279.20 | −2% | vs KIMS |
| The Ensign Group ENSG | $188.41 | $140.09 | −26% | vs KIMS |
| Encompass Health Corporation EHC | $140.99 | $94.81 | −33% | vs KIMS |
| Fresenius SE FRE | €53.86 | €34.77 | −35% | vs KIMS |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,771 | ₹5,234 | −40% | vs KIMS |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 211.40 SAR | 109.45 SAR | −48% | vs KIMS |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Krishna Institute of Medical Sciences Limited (KIMS) overvalued or undervalued?
What is the fair value of KIMS?
What is the quality score of KIMS?
What is the price target for Krishna Institute of Medical Sciences Limited (KIMS)?
What is the Krishna Institute of Medical Sciences Limited stock forecast for 2026?
What is the revenue of Krishna Institute of Medical Sciences Limited (KIMS)?
What is the intrinsic value of Krishna Institute of Medical Sciences Limited (KIMS)?
Is Krishna Institute of Medical Sciences Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of KIMS?
How much is Krishna Institute of Medical Sciences Limited worth?
What do the bullish and bearish scenarios say about KIMS?
What is the P/E ratio of KIMS?
How solid is the balance sheet of Krishna Institute of Medical Sciences Limited (KIMS)?
How far is KIMS from its 52-week high?
Which stocks are comparable to Krishna Institute of Medical Sciences Limited?
Is Krishna Institute of Medical Sciences Limited stock attractive at the current price?
How is the fair value of KIMS calculated?
Is it still worth investing in stocks now?
What is the share price of Krishna Institute of Medical Sciences Limited (KIMS)?
What should I pay attention to with Krishna Institute of Medical Sciences Limited right now?
Where does the earnings growth of Krishna Institute of Medical Sciences Limited (KIMS) come from?
Key figures of Krishna Institute of Medical Sciences Limited
How large is the market capitalisation of Krishna Institute of Medical Sciences Limited (KIMS)?
What is the P/S ratio of Krishna Institute of Medical Sciences Limited (KIMS)?
What are the earnings per share of Krishna Institute of Medical Sciences Limited (KIMS)?
What is the net margin of Krishna Institute of Medical Sciences Limited (KIMS)?
What is the return on equity of Krishna Institute of Medical Sciences Limited (KIMS)?
What is the EBIT return on assets of Krishna Institute of Medical Sciences Limited (KIMS)?
What is the operating margin of Krishna Institute of Medical Sciences Limited (KIMS)?
How fast is revenue growing at Krishna Institute of Medical Sciences Limited (KIMS)?
How fast are earnings growing at Krishna Institute of Medical Sciences Limited (KIMS)?
How much free cash flow does Krishna Institute of Medical Sciences Limited (KIMS) generate?
How much net debt does Krishna Institute of Medical Sciences Limited (KIMS) carry?
Watch Krishna Institute of Medical Sciences Limited in the live analysis
One click puts Krishna Institute of Medical Sciences Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.